Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1987 Jan;42(1):26–31. doi: 10.1136/thx.42.1.26

Trial of ketoconazole in non-invasive pulmonary aspergillosis.

D J Shale, J A Faux, D J Lane
PMCID: PMC460599  PMID: 3303424

Abstract

A one year study of the efficacy of the antifungal agent ketoconazole in non-invasive pulmonary aspergillosis was carried out. Ten patients, seven with allergic bronchopulmonary aspergillosis and three with mycetoma, were studied. They were randomly allocated to receive 400 mg daily or placebo orally in a double blind fashion. In the treated group (n = 6), concentrations of serum IgG specific for Aspergillus fumigatus fell significantly during treatment (mean reduction 42% (SEM 2.2%) compared with determinations preceding the study). This effect was evident by three months and continued for the 12 months of treatment. Patients receiving placebo (n = 4) showed no significant change in serum IgG concentration (mean change + 10% (SEM 5.3%]. Asthmatic patients treated with ketoconazole (n = 4) had significantly lower symptom scores than those receiving placebo (n = 3) (+0.45%/month (SEM 6.9%) versus +27%/month (SEM 6.5%); p less than 0.001). None of the patients treated with ketoconazole reported any adverse effects. Ketoconazole may cause serious liver damage but its use may be justified in bronchopulmonary aspergillosis if further experience confirms its ability to alter the course of a potentially serious disease.

Full text

PDF
26

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basich J. E., Graves T. S., Baz M. N., Scanlon G., Hoffmann R. G., Patterson R., Fink J. N. Allergic bronchopulmonary aspergillosis in corticosteroid-dependent asthmatics. J Allergy Clin Immunol. 1981 Aug;68(2):98–102. doi: 10.1016/0091-6749(81)90165-2. [DOI] [PubMed] [Google Scholar]
  2. EDWARDS G., LATOUCHE C. J. THE TREATMENT OF BRONCHOPULMONARY MYCOSES WITH A NEW ANTIBIOTIC--PIMARICIN. Lancet. 1964 Jun 20;1(7347):1349–1353. doi: 10.1016/s0140-6736(64)92038-0. [DOI] [PubMed] [Google Scholar]
  3. Greenberger P. A., Patterson R., Ghory A., Arkins J. A., Walsh T., Graves T., Saker J. Late sequelae of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 1980 Oct;66(4):327–335. doi: 10.1016/0091-6749(80)90029-9. [DOI] [PubMed] [Google Scholar]
  4. Henderson A. H., English M. P., Vecht R. J. Pulmonary aspergillosis. A survey of its occurrence in patients with chronic lung disease and a discussion of the significance of diagnostic tests. Thorax. 1968 Sep;23(5):513–518. doi: 10.1136/thx.23.5.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Henderson A. H., Pearson J. E. Treatment of bronchopulmonary aspergillosis with observations on the use of natamycin. Thorax. 1968 Sep;23(5):519–523. doi: 10.1136/thx.23.5.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hepatitis and ketoconazole therapy. Br Med J (Clin Res Ed) 1981 Oct 17;283(6298):1058–1059. [PMC free article] [PubMed] [Google Scholar]
  7. Jewkes J., Kay P. H., Paneth M., Citron K. M. Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax. 1983 Aug;38(8):572–578. doi: 10.1136/thx.38.8.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lewis J. H., Zimmerman H. J., Benson G. D., Ishak K. G. Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases. Gastroenterology. 1984 Mar;86(3):503–513. [PubMed] [Google Scholar]
  9. Malo J. L., Hawkins R., Pepys J. Studies in chronic allergic bronchopulmonary aspergillosis. 1. Clinical and physiological findings. Thorax. 1977 Jun;32(3):254–261. doi: 10.1136/thx.32.3.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mullins J., Harvey R., Seaton A. Sources and incidence of airborne Aspergillus fumigatus (Fres). Clin Allergy. 1976 May;6(3):209–217. doi: 10.1111/j.1365-2222.1976.tb01899.x. [DOI] [PubMed] [Google Scholar]
  11. NOBLE W. C., CLAYTON Y. M. FUNGI IN THE AIR OF HOSPITAL WARDS. J Gen Microbiol. 1963 Sep;32:397–402. doi: 10.1099/00221287-32-3-397. [DOI] [PubMed] [Google Scholar]
  12. Patterson R., Greenberger P. A., Radin R. C., Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med. 1982 Mar;96(3):286–291. doi: 10.7326/0003-4819-96-3-286. [DOI] [PubMed] [Google Scholar]
  13. Radin R. C., Greenberger P. A., Patterson R., Ghory A. Mould counts and exacerbations of allergic bronchopulmonary aspergillosis. Clin Allergy. 1983 May;13(3):271–275. doi: 10.1111/j.1365-2222.1983.tb02598.x. [DOI] [PubMed] [Google Scholar]
  14. Rafferty P., Biggs B. A., Crompton G. K., Grant I. W. What happens to patients with pulmonary aspergilloma? Analysis of 23 cases. Thorax. 1983 Aug;38(8):579–583. doi: 10.1136/thx.38.8.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ricketti A. J., Greenberger P. A., Mintzer R. A., Patterson R. Allergic bronchopulmonary aspergillosis. Arch Intern Med. 1983 Aug;143(8):1553–1557. [PubMed] [Google Scholar]
  16. Rosenberg M., Patterson R., Mintzer R., Cooper B. J., Roberts M., Harris K. E. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med. 1977 Apr;86(4):405–414. doi: 10.7326/0003-4819-86-4-405. [DOI] [PubMed] [Google Scholar]
  17. Rosenberg M., Patterson R., Roberts M., Wang J. The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis. Am J Med. 1978 Apr;64(4):599–606. doi: 10.1016/0002-9343(78)90579-x. [DOI] [PubMed] [Google Scholar]
  18. Safirstein B. H., D'Souza M. F., Simon G., Tai E. H., Pepys J. Five-year follow-up of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis. 1973 Sep;108(3):450–459. doi: 10.1164/arrd.1973.108.3.450. [DOI] [PubMed] [Google Scholar]
  19. Shale D. J., Faux J. A. The evaluation of a quantitative enzyme-linked immunosorbent assay (ELISA) for anti-Aspergillus fumigatus IgG. J Immunol Methods. 1985 Mar 18;77(2):197–205. doi: 10.1016/0022-1759(85)90032-8. [DOI] [PubMed] [Google Scholar]
  20. Slavin R. G., Stanczyk D. J., Lonigro A. J., Broun G. O. Allergic bronchopulmonary aspergillosis--a North American Rarity. Clinical and immunologic characteristics. Am J Med. 1969 Aug;47(2):306–313. doi: 10.1016/0002-9343(69)90156-9. [DOI] [PubMed] [Google Scholar]
  21. Stark J. E. Allergic pulmonary aspergillosis successfully treated with inhalations of nystatin. Report of a case. Dis Chest. 1967 Jan;51(1):96–99. doi: 10.1378/chest.51.1.96. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES